ConductScience.org, home

Paper39400342

The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy.

Rencuzogullari A and 13 others. J Surg Oncol, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy. Papers, record 39400342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39400342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy.
PubMed
Journal
J Surg Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.33, provisional
iCite
Revised in PubMed
2025-05-03
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rencuzogullari AAhmet
2Karahan SNSalih Nafiz
3Selcukbiricik FFatih
4Lacin SSahin
5Taskin OCOrhun Cig
6Saka BBurcu
7Karahacioglu DDuygu
8Gurses BBengi
9Ozoran EEmre
10Uymaz DSDerya Salim
11Ozata IHIbrahim Halil
12Saglam SSezer
13Bugra DDursun
14Balik EEmre

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stomach NeoplasmsMajor topic
Neoadjuvant TherapyMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
AdenocarcinomaMajor topic
Perioperative CareMajor topic
Humans
Male
Female
Middle Aged
Docetaxel
Epirubicin
Propensity Score
Leucovorin
Aged
Retrospective Studies
Fluorouracil
Oxaliplatin
Survival Rate
Gastrectomy
Follow-Up Studies
Chemotherapy, Adjuvant
Adult

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
The authors received no specific funding for this work.PubMed

Source PubMed

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137015332Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2023https://conductscience.org/library/papers/37015332PubMed
229566109Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.JAMA Oncol2018https://conductscience.org/library/papers/29566109PubMed
330174850Impact of pathological complete response following neoadjuvant chemoradiotherapy in esophageal cancer.J Thorac Dis2018https://conductscience.org/library/papers/30174850PubMed
437963317
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol2024https://conductscience.org/library/papers/37963317PubMed
532487637Hydro-MDCT for Gastric Adenocarcinoma Staging. A Comparative Study With Surgical and Histopathological Findings for Selecting Patients for Echo-endoscopy.Anticancer Res2020https://conductscience.org/library/papers/32487637PubMed
615383798Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.Ann Surg2004https://conductscience.org/library/papers/15383798PubMed
733024393Artificial intelligence in gastric cancer: Application and future perspectives.World J Gastroenterol2020https://conductscience.org/library/papers/33024393PubMed
831582518ctDNA in Gastric and Gastroesophageal Cancer: Prognostic, Predictive, or Preliminary?Clin Cancer Res2019https://conductscience.org/library/papers/31582518PubMed
923213098
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution.
J Clin Oncol2013https://conductscience.org/library/papers/23213098PubMed
1010655437
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
J Natl Cancer Inst2000https://conductscience.org/library/papers/10655437PubMed
1116822992Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med2006https://conductscience.org/library/papers/16822992PubMed
1233798955Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.Cancer Treat Rev2021https://conductscience.org/library/papers/33798955PubMed
1331109837The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer.Urol Oncol2019https://conductscience.org/library/papers/31109837PubMed
1422734012Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.Ann Oncol2012https://conductscience.org/library/papers/22734012PubMed
1535535555MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer.Future Oncol2022https://conductscience.org/library/papers/35535555PubMed
1630982686
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet2019https://conductscience.org/library/papers/30982686PubMed
1738134948
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Lancet Oncol2024https://conductscience.org/library/papers/38134948PubMed
1835876385CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.Ann Surg2022https://conductscience.org/library/papers/35876385PubMed
1932040809Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment.J Gastrointest Surg2021https://conductscience.org/library/papers/32040809PubMed
2036842787Gastric adenocarcinoma: A review of the TNM classification system and ways of spreading.Radiologia (Engl Ed)2023https://conductscience.org/library/papers/36842787PubMed

See all 23 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42882832Neoadjuvant Advantage, Adjuvant Challenge: Clinical Evidence and Hypothetical Biological Mechanisms Behind Divergent Tolerability.Cancers (Basel)2026https://conductscience.org/library/papers/42882832PubMed
42812350Gastric cancer and the TNT era: have we solved the timing question, or only redistributed the treatment?Front Oncol2026https://conductscience.org/library/papers/42812350PubMed
42057888Safety and feasibility of total neoadjuvant FLOT chemotherapy in locally-advanced gastric and gastroesophageal junction cancer.Oncol Lett2026https://conductscience.org/library/papers/42057888PubMed
42038345Pretreatment C-reactive protein-triglyceride-glucose index predicts survival in patients with FLOT-treated locally advanced gastric and gastroesophageal junction cancer.Oncol Lett2026https://conductscience.org/library/papers/42038345PubMed
41859180Perioperative chemotherapy (FLOT 4 + 4) versus total neoadjuvant therapy (TNT; FLOT ×8) for resectable gastric cancer: A systematic review and exploratory meta-analysis.Surg Open Sci2026https://conductscience.org/library/papers/41859180PubMed
41787276The role of GP73 in predicting overall survival and chemotherapy response in locally advanced gastric cancer: a retrospective cohort study.BMC Gastroenterol2026https://conductscience.org/library/papers/41787276PubMed
41753172
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.
J Clin Med2026https://conductscience.org/library/papers/41753172PubMed
40962962Is More Really Better? Intensive Neoadjuvant Therapy and Standard Perioperative FLOT for Locally Advanced Gastric Cancer Demonstrate Similar Short-Term Outcomes.Ann Surg Oncol2025https://conductscience.org/library/papers/40962962PubMed
40115020Perioperative versus adjuvant chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials.Front Oncol2025https://conductscience.org/library/papers/40115020PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39400342

GET https://conductscience.org/api/papers/v1/39400342/references?page=2